Joel E Kleinman Selected Research

metabotropic glutamate receptor 3 (mGluR3)

12/2020	Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition.
11/2016	Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.
11/2008	Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.
10/2008	Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel E Kleinman Research Topics

Disease

71	Schizophrenia (Dementia Praecox) 01/2022 - 05/2002
10	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 10/2004
8	Mental Disorders (Mental Disorder) 03/2022 - 12/2002
5	Major Depressive Disorder (Major Depressive Disorders) 12/2020 - 12/2004
5	Mood Disorders (Mood Disorder) 01/2020 - 05/2002
4	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 03/2003
4	Substance-Related Disorders (Drug Abuse) 01/2018 - 12/2006
3	Alzheimer Disease (Alzheimer's Disease) 09/2015 - 01/2011
3	Neurodevelopmental Disorders 01/2015 - 09/2003
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2018
2	Cognitive Dysfunction 06/2014 - 08/2010
2	Fasciculation (Fasciculations) 04/2006 - 01/2006
2	Classical Lissencephalies and Subcortical Band Heterotopias 04/2006 - 01/2006
1	Opiate Overdose 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Necrosis 10/2016
1	Pitt-Hopkins syndrome 04/2016
1	Weight Gain 11/2015
1	Obesity 11/2015
1	Dementia (Dementias) 09/2015
1	Central Nervous System Diseases (CNS Diseases) 03/2013
1	Inflammation (Inflammations) 01/2013
1	Neuroinflammatory Diseases 01/2013
1	Autistic Disorder (Autism) 08/2010
1	Parkinson Disease (Parkinson's Disease) 04/2010

Drug/Important Bio-Agent (IBA)

32	Messenger RNA (mRNA)IBA 12/2020 - 08/2003
17	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2004
12	Protein Isoforms (Isoforms)IBA 01/2021 - 04/2006
10	RNA (Ribonucleic Acid)IBA 03/2022 - 12/2004
5	Neuregulin-1 (Neuregulin 1)IBA 09/2014 - 04/2006
5	Dopamine (Intropin)FDA LinkGeneric 11/2008 - 03/2003
4	Glutamic Acid (Glutamate)FDA Link 12/2020 - 01/2004
4	metabotropic glutamate receptor 3 (mGluR3)IBA 12/2020 - 10/2008
4	Pharmaceutical PreparationsIBA 01/2020 - 12/2006
4	Biological ProductsIBA 01/2018 - 07/2012
3	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 03/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
3	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2019
3	NeuregulinsIBA 01/2017 - 08/2010
3	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 07/2011
3	DNA (Deoxyribonucleic Acid)IBA 10/2012 - 09/2008
3	EnzymesIBA 01/2011 - 06/2004
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2008 - 01/2004
3	Estrogen Receptor alphaIBA 08/2008 - 12/2004
2	Opioid Analgesics (Opioids)IBA 01/2021 - 03/2008
2	Olanzapine (Zyprexa)FDA Link 01/2019 - 09/2013
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2008
2	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 09/2014
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2015 - 12/2002
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2015 - 10/2004
2	Apolipoprotein E4IBA 09/2015 - 01/2015
2	Cocaine (Cocaine HCl)IBA 03/2008 - 12/2006
2	DysbindinIBA 01/2008 - 06/2004
2	ElementsIBA 04/2006 - 01/2006
2	neurabinIBA 10/2004 - 06/2004
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2004 - 09/2003
1	Netrin-1IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	ArsenicIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	EndocannabinoidsIBA 01/2020
1	Sorting NexinsIBA 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2020
1	AntibodiesIBA 11/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2016
1	InterferonsIBA 10/2016
1	CytokinesIBA 10/2016
1	Transcription Factor 4IBA 04/2016
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	Nicotine FDA Link 01/2016
1	arsenite methyltransferaseIBA 01/2016
1	Amyloid beta-PeptidesIBA 09/2015
1	ChromatinIBA 01/2015
1	Sodium Channels (Sodium Channel)IBA 06/2014
1	Member 2 Solute Carrier Family 12IBA 04/2014
1	CationsIBA 04/2014
1	CateninsIBA 08/2013
1	Serotonin (5 Hydroxytryptamine)IBA 03/2013
1	CannabinoidsIBA 11/2012
1	Amphetamine (Amfetamine)FDA LinkGeneric 07/2012
1	triphosphoric acid (triphosphate)IBA 07/2012
1	phosphoinositide-3,4,5-triphosphateIBA 07/2012
1	IC 87114IBA 07/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2012
1	N 30IBA 07/2011
1	Calcium Channels (Calcium Channel)IBA 09/2010
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2010
1	Phosphotransferases (Kinase)IBA 12/2009
1	StathminIBA 12/2009
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2009
1	metabotropic glutamate receptor 2IBA 11/2008
1	Estrogens (Estrogen)FDA Link 08/2008
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2008
1	Phencyclidine (Angel Dust)IBA 03/2008

Therapy/Procedure

1	Therapeutics 09/2009